Serenity: Greenliant (Harmonic Drive) as the "Best-Positioned Play" in the Humanoid Robot Space
Claire Weston
Market analyst Serenity publicly named Leaderdrive (688017) on X as the top A-share pick in humanoid robotics — the core thesis is 'whoever wins, this company sells the parts,' but the analyst disclosed no position or conflicts, and investors should judge for themselves.
Why is an overseas analyst suddenly spotlighting this company?
X user Serenity (@aleabitoreddit) published a post calling Leaderdrive the "best-positioned play" in the humanoid-robotics sector.
The thesis is not about near-term earnings. It is a directional long bet: whichever robotics firm reaches mass production first, Leaderdrive stands to profit as a component supplier.
In plain terms = this is a "sell the shovels" play — in a gold rush, don't bet on who finds gold; bet on the fact that everyone needs a shovel.
What does it actually sell? Why "inside every robot"?
The product line spans harmonic reducers (precision gear sets that control robot-joint rotation), rotary reducers, linear actuators (components converting rotary motion into straight-line motion), motors, and joint modules — with expansion into planetary roller screws.
Per the analyst's cited data, Leaderdrive holds over 60% of China's harmonic-reducer market and serves more than 1,800 clients globally.
On a rough BOM (bill of materials) basis, these core components account for 4% to 15% of a single humanoid robot's cost — a share that could rise as the company enters more sub-segments.
Who are its customers — and who might be next?
Current clients include Universal Robots, UBTech, and Agibot (智元机器人).
The analyst lists Tesla and Figure among potential future customers.
This means → if leading Western robotics firms tap China's supply chain at the mass-production stage, Leaderdrive is among the most likely component suppliers to be locked in.
How deep is the "cost moat"?
The analyst emphasizes that China leads on the path to scaled manufacturing — most Western competitors cannot match Leaderdrive's cost structure.
This reflects a broader industry signal: the cost battle in humanoid robotics is essentially an extension of China's overall manufacturing-cost advantage.
Recent financials offer some fundamental support: 2025 revenue reached ¥569 million, up 46.86% year-on-year; net profit hit ¥125 million, up 122.40%.
How should it be valued? Where is the risk?
The analyst admits that traditional DCF or earnings-forecast models cannot price this kind of company — value realization depends almost entirely on "how many humanoid robots actually reach mass production in the next few years."
In plain terms = this is not an investment you can spreadsheet your way through. The bet is on the sector's industrial tempo; the individual stock's alpha is secondary.
Key caveat: the analyst disclosed no position size, cost basis, or conflict-of-interest statement. High upside elasticity also means valuation-reversal risk is real — investors should weigh their own risk tolerance carefully.
Content is for reference only, not financial advice.